Besides, Feng et al. study was conducted in 19 ALK-rearranged Western NSCLC patients with early or advanced stages, whereas ours was in 160 ALK-positive Eastern metastatic cases. The gene discussed is ALK; the disease is non-small cell lung carcinoma.